
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI)
A key member of Rezolute’s Technical Operations Leadership team, the Head of Global Product Supply has the mandate to provide the vision, leadership, strategy and management skills to build, lead and oversee the team’s transition from the development and supply of proprietary clinical stage programs to a fully externalized, globally enabled and integrated manufacture and supply team, supporting direct and partnered markets. In particular, the Head of Global Product Supply will have oversight over the company’s externalized manufacturing and supply chain platform, supporting the submission, approval, launch and supply of ersodetug, globally. The position reports to the Head of Operations, working daily in collaboration with the Head of Quality, Clinical Operations, Commercial Leadership Team, Regulatory and the RZLT Management Team, while acting as a pivotal source of information for the Board of Directors.
Provides oversight, leadership and management as needed to meet program milestones, manufacturing of drug substance, drug product and finished drug product. In parallel provides executive leadership, management to guidance to addresses risks associated with global supply of Investigational Product to depots, subdepots and clinical sites through an existing Clinical Supply Team.
Works to continuously develop the manufacturing and supply chain operation and teams to ensure robustness and reliability of supply; Will rebuild the clinical supply chain as a priority through hiring or key resource, definition and deployment of process and procedure, and robust management and monitoring of daily execution.
Works closely with Quality, Clinical Operations, Regulatory and Finance to sustain a very dynamic clinical supply program, continuing to identify shortfalls or risks to supply; Leads an agile team to successful outcomes in support of near-term Corporate Goals/Strategy and Milestones.
Accountable for identification, implementation and maintenance of robust manufacturing, inventory management and supply systems
Leads a team to collaboratively (Quality, MSAT and the Technical Operations Leadership) resolve deviations and investigations, enabling on-time reliable supply.
Accountable for and partners with key functions (Commercial Ops, Market Access, Patient Services, Finance) to establish and sustain an S&OP process, arriving at supply and demand models, COGs, and spend, to support clinical and commercial supply.
Works cross functionally to identify product lifecycle needs, enabling feasibility, development and implementation in concert with product and corporate strategy.
Applies suitable governance structure with external suppliers to drive at open, contemporaneous and clear understanding of conduct of work, costs, risks and deliverables.
Rezolute (RZLT) currently anticipates the base salary for the Head of Global Product Supply role could range from $290,000 to $340,000 and will depend, in part, on the successful candidate’s geographical location and their qualifications for the role, including education and experience. This position will also be eligible for an annual performance bonus in accordance with the terms of the applicable plan (depending, in part, on company and individual performance and at the Company’s discretion on an individual basis). The compensation described above is subject to change and could be higher or lower than the range described based on current market survey data and the qualifications, education, experience, and geographical location of the selected candidate.
Qualifying employees are eligible to participate in benefit programs such as:
We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class.

Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI).
For more information, visit: www.rezolutebio.com.